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Abstract  
At present, the biggest challenge to health and economic systems around the world is the emergence of COVID-
19 pandemic. Several ethical questions have been raised at the macro-, meso- and micro-levels with respect to 
proper management and control of this pandemic. The most important factor in creating fear and public 
anxiety and disturbances of social functions is the fatalities caused by the epidemic by an unknown pathogen 
in most countries. Decisions for epidemic control measures are made among many uncertainties, and prioritize 
public health over individual rights. People's trust and compliance with recommendations play a decisive role 
in public actions. Therefore, during an epidemic, necessities such as adherence to the values of honesty, 
respect, human dignity, solidarity, justice, reciprocity, transparency, and responsiveness in the response 
system need to be considered. The major ethical considerations in macro and micro levels of decision-making 
responding to the COVID-19 will be reviewed in this paper. Ethical dilemmas arise in different domains of a 
pandemic such as restriction on freedom of movement, individual’s refusal of preventive or therapeutic 
interventions, health care workers’ rights and duty to care, the allocation of scarce resources, off-label use of 
diagnostic and therapeutic measures and research. The purpose of this article is to pay attention to ethical 
principles in solving these challenges and does not necessarily respond to all ethical problems; however, it 
draws the reader's attention and moral sensitivity to the issues raised in this area. 
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CONTEXT
On the last day of 2019, China announced 
unexplained pneumonia clusters to the World 
Health Organization (WHO). The disease, called 
COVID-19, quickly spread beyond the borders of 
China so that, in less than two and a half months, 
turning it into a pandemic was declared by the 
World Health Organization on March 11, 2020 (1). 
In addition to the challenges to the public health 
system, epidemics pose some ethical problems as 
well (2). Some of these challenges are in conjunction 
with the macro-management of public health 
response, and some ethical issues occur in the 
context of patient care for health care providers. In 
general, the most important ethical value in public 
health, a subset of which is pandemic, is solidarity. 
Given that the benefits of public health are 
prioritized over the individual's interests during 
the incidence of an infectious epidemic, this will 
reduce people's autonomy (3). In the evaluation of 
risk and benefits, the patient’s one is not merely 
raised, and it should be assessed in balance with 
the health interests of the whole society. On the 
other hand, these conditions raise the issue of 
justice in access to resources (4). One factor that can 
exacerbate health inequality is the vulnerability of 
the disadvantaged and vulnerable groups in society 
to the epidemic. The epidemic response is 
generally conducted in uncertainty and social 
disruption (5). The inefficient epidemic response 
wastes resources and undermines the power of the 
health system and exacerbates public anger and 
disorder. Trust and cooperation of the people are 
essential for the efficacy of the programs in the 
epidemic response. Paying attention to ethical 
considerations in the outbreak and taking an 
ethical approach, are beneficial in maintaining 
public trust and confidence. 
In this article, a brief overview of the ethical 
considerations, most of the affected countries with 
COVID-19 pandemic are dealing with, is presented. 
Although, ethical considerations are often the same 
in infectious epidemics, the severity of ethical 
challenges can be different in each epidemic and 
each society. 
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International Responsibilities of Countries 
The experience of recent pandemic demonstrated 
that governments must not only commit 
themselves to the health status of individuals 
within their borders but also they are responsible 
to prevent the spread of the epidemic to other 
countries (6, 7). The pandemic mainly damages the 
economy and the health of the countries with 
limited resources. Sanctions and wars are 
international determinants of poor health which 
hinder the situations to control the transformation 
of the epidemic into a pandemic (8, 9). International 
solidarity to prevent the spread of the disease to 
other countries, as well as to aid to countries with 
poor infrastructure to allow rapid response to the 
epidemic is critical (10).  
Through prompt notification of events and 
providing reliable statistics to the international 
community, countries are ethically bound to help 
prevent the spread of the disease (11). On the other 
hand, other countries in the world, which their 
resources and people’s lives are saving in this way, 
have a reciprocity duty to humanitarian aid to 
affected countries for the supply of personal 
protective equipment, medication and research & 
development on diagnostics, therapeutics, and 
vaccine. Thus, the capacities of other countries 
should be employed to restrain the spread of the 
epidemic in the country of origin and to help limit 
the damage caused by it in the country of origin (12). 
We have lost the time and now the pandemic 
affected many countries. However, the well-off 
countries still have a duty to allocate funds for 
research on managing the pandemic. Attempts for 
the development of vaccines or drugs should 
include the limitations of patenting so that it can 
guarantee the fair access of all people around the 
world to this scientific achievement of the health. 
Vulnerable people 
Although saving the lives of more people is 
considered as the paramount ethical principle in 
the epidemic response, fair distribution of benefits 
and damages resulting from the pandemic 
response should not be overlooked. As all countries 
do not suffer damages from the pandemic at the 
same level, different groups of a community 
experience dissimilar influences from the 
epidemic. People whose economic income 
entangles in difficulty due to restrictions on 
movement such as isolation, travel restrictions, or 
quarantine, people who are at increased risk of 
infection due to living in nursing homes or being in 
jails, people who are deprived of access to health 
information because of impairment in the ability to 
establish communication (such as illiteracy, 
hearing loss, lack of familiarity with the local 
language), marginalized groups who may be more 
exposed to discrimination as a result of the 
incidence of an epidemic, and groups that have no 
access to good health status through the social 
determinants of health are all examples of 
situations of vulnerability in the epidemic. Equity 
necessitates that more attention be paid to these 
groups’ needs and that greater resources be 
assigned for the delivery of services to them (13-15). 
Allocation of Scarce Resources 
In the spread of the Coronavirus epidemic to all 
areas of a country, in practice, there might not be 
possible to provide needed resources by mobilizing 
them. The shortage of hospital beds, manpower, 
medicine and equipment are among the limitations 
of resources in the epidemic. Following the 
increase in the number of afflicted persons, in the 
COVID-19 crisis, serious discussions on 
determining the criteria for ventilator allocation 
were raised in different countries (16-19). In making 
decisions to allocate the resources, a balance 
between utility and equity needs to be achieved (20). 
Enhancement of the utility in the ventilator 
allocation requires that resources be dedicated to 
people who have more chance of surviving. Equity 
demands that services be delivered to those who 
need more than anyone, and vulnerable people 
should not be systematically eliminated from 
receiving resources. Moreover, it is essential to 
determine will only the number of lives preserved 
be the criterion for estimating utility, or will the 
long-term survival of patients (years of life 
preserved) be the criterion? For example, if a 
person who has a shorter life due to cancer or 
congenital disorder to be placed in a lesser priority 
to receive a ventilator compared to a healthy 
person who needs the ventilator to the same extent 
and enjoys the same chance of survival, although 
more years of life have been preserved, this will be 
systematically to the detriment of those who suffer 
from a disease in the natural lottery that shortens 
their lifetime relative to their peers.  
On the other hand, taking into account the factor of 
age on the basis of the principles of life cycle seems 
to be ethical. This means that a person with 30 
years old has not yet had the possibility of 
enjoyment of long life compared to a person with 
70 years old, and it's fair to say that, between the 
prior and the latter ones, the young person has a 
higher priority to receive a ventilator. Another 
important issue in the discussion of ventilator 
allocation is that withholding and withdrawing the 
device have no ethical difference from one another. 
In some religions, including the view of Iranian 
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Shiite scholars, there is a difference between the 
two, and disconnecting the device is considered to 
be manslaughter (21). Although depriving the 
patient of receiving the device is accepted in terms 
of the jurisprudence, in some instance it eliminates 
the possibility of a closer examination of the 
response to the ventilator and the chance of more 
survival of the patient, which even in the school of 
Islamic ethics, it is in contradictory with the 
principle of preserving human life (22). To fix the 
problem, some experts in the fields of 
intensive care unit (ICU), ethics, jurisprudence, and 
law must discuss various considerations of the 
intended resource allocation together and come to 
conclusions. 
Restrictions on the Movement of Citizens 
Commonly, to minimize the transmission of 
infection, restriction on the freedom of movement 
of people, such as travel restrictions, restrictions 
on gatherings, isolation of sick people, and 
quarantine of people with close contact is crucial 
which each of them is somehow considered as a 
restriction for the autonomy of individuals. Overall, 
to exert the restrictions on the freedom of 
movement, the lowest level of infringement on 
personal autonomy, which is effective and 
proportional to prevent the spread of infection, 
must be applied. The voluntary restriction of 
movement is preferred over the forced one (23, 24).  
Hence, providing honest, continuous and respectful 
communication to gain social acceptance and 
compliance is necessary. As a result of restrictions 
on freedom of movement, many people may lose 
their earnings, or even their careers, or experience 
illness stigma (25). In applying the restrictions on 
movement, reciprocity requires that the basic 
needs of restricted people to be met, and human 
dignity requires that they get due respect and their 
human need to engagement in purposeful activities 
and communication with their loved ones be 
respected. Furthermore, to prevent the 
stigmatization and harassment of people under 
quarantine and isolation, public educations need to 
be provided in order to correct people’s 
misconceptions (20). Moreover, affected people 
should have opportunities to make their voices 
heard and challenge the decisions they believe to 
be unfair.  
The Rights of COVID-19 Patients  
Concern about death and distancing from others 
leads to serious anxiety and stress for patients. 
During their hospitalization, the COVID-19 patients 
see health care providers only from behind masks, 
face shields and gowns, so recognizing them and 
building human relationships with them are 
difficult for patients. This necessitates the need for 
establishing empathetic communication and 
paying attention to the mental and emotional 
concerns of patients by health care providers. 
Moreover, in the hospital setting, patients are 
isolated in no visitor status. The loneliness of 
patients, while intensifying their emotional 
concerns, raises the physical needs concerns that 
were previously might be met by their companions 
(26). Some patients have mobility impairments, and 
some others suffer from communication 
disabilities. The limitation of the number of health 
care providers does not make it possible to 
respond to all the needs of patients. The 
recruitment of the minimum number of trained 
volunteers among the infection survivors to meet 
the needs of patients may be an appropriate 
strategy to address this challenge. 
One of the other challenges for the patients is the 
privacy of their identity. Different surveillance 
systems include their identity information. 
Preventing the access of researchers and people 
outside the treatment team to identifiable data is 
essential (27-29). During the treatment of patients, 
many biological samples are collected for their 
care. Maintaining additional samples and the use of 
them for research necessitate considering the 
confidentiality in sharing samples and obtaining 
the patient’s informed consent where samples are 
identifiable or research results can cause a risk to 
the patient or his/her community (30, 31). 
One of the other ethical challenges in pandemic 
response measures is dealing with individual’s 
refusal of diagnostic, therapeutic, or preventive 
measures (32). Providing understandable and 
enough information for patient’s voluntary 
informed decision-making is the default in all 
health interventions. Always, optional and 
voluntary measures take precedence over forced 
measures in all public health interventions. 
However, sometimes the patient refuses to stay at 
the hospital or get treatment. In these cases, similar 
to any discharge against medical advice, efforts 
should be made to identify and address the 
concerns of the patient. In the epidemic response 
measures, overriding an individual’s refusal of 
interventions is ethically acceptable only if 1) the 
refusal pose public health risk, and 2) the 
intervention is effective to prevent harm to others, 
and 3) there is not any solution to protect the 
health of others, other than the intended 
intervention (20). Until there is a cooperation of 
the patient for isolation at home and there are 
people to take care of him/her, forced isolation at a 
shelter is not required. 
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The Responsibilities and Rights of Frontline 
workers in the Epidemic Response 
All those who are continuously exposed to patients 
or contaminated substances due to their work, 
whether as the main labor force or as a volunteer, 
are frontline workers. Reciprocity to frontline staff 
requires that necessary personal protective 
equipment should be provided to them, and they 
should take priority for treatment if they get sick. 
Higher safety and treatment priority of these 
people is also of special importance in terms of 
maintaining the needed human resources for the 
delivery of services to greater patients (increased 
utility) (33). The epidemic response is associated 
with ethical distresses and psychological 
challenges, and staff on the frontline must be 
prepared and supported to deal with these 
challenges and uncertainties (20, 34). 
A serious ethical question about the level of 
acceptable risk in service delivery, where 
resources are extremely limited, and there is 
insufficient protective equipment, arises. In the 
incidence of the pandemic, unfortunately, all 
countries confront challenges in the supply of 
personal protective device ideals. Patients and the 
public at risk of an epidemic expect health care 
workers who are the professional in control of the 
infection, to employ their knowledge and skills to 
help people, even in limited resources (35). 
Nevertheless, this does not mean the acceptance of 
any level of risk. Cases where staff is endangered by 
serious life-threatening risks should not be 
persuaded to provide services (36). Measures that 
can help provide services in critical circumstances 
are the resource management for mobilizing 
protective equipment to high-risk environments 
and the use of COVID-19 survivors in these 
environments (37, 38). 
Research during Pandemic 
During a pandemic, we need to carry out different 
types of research to find out the reliable answers to 
questions about managing the epidemic. The 
necessity of prompt access to the reliable results of 
these investigations makes necessary the speed in 
the process of ethical and scientific review of these 
studies. Based on a report, 153 articles were 
published about this pandemic from the beginning 
of January to February 19, whereas half of this in a 
year was released in the case of the SARS epidemic. 
On the basis of this report, 60% of all articles on the 
COVID are in the pre-printed forms (39). Early 
publication without peer review can provide 
erroneous information and entails false 
conclusions in public health response and patient 
care. 
How much health budget is allocated to research, is 
another ethical consideration. Research, 
particularly in developing countries, should not 
lead to a shift of resources from the epidemic 
response and treatment to research. As well as, it is 
essential that research be done in conjunction with 
epidemic response measures as much as possible 
and do not have any interference with them (40, 41). 
Conducting research during a pandemic requires 
prompt ethical approval. However, prompt 
approval should not detract from the ethical 
standards of research. All standards of ethics in 
research must be respected in investigations 
carried out on the COVID-19 epidemic (41-43). In the 
pandemic of the recent infectious disease, for 
which a definitive cure (absolute treatment) has 
not yet been found, any kind of experimental 
medications may be perceived to be therapeutic 
intervention by patients. Patients need to be given 
sufficient information about the research and 
freedom to make an informed decision for 
participation in the study (41, 43-45). 
Publishing articles based on the analysis of 
pandemic surveillance data raise the discussion of 
data ownership and copyright (46, 47). Many 
physicians and health care institutes are involved 
in patient care and gathering pandemic 
surveillance data, but there are few who have 
access to the whole data. In order to protect their 
ownership, researcher and/or medical centers may 
avoid sharing their data. The prompt data sharing 
is extremely important for improving the statistical 
power of studies; it also provides the possibility of 
verifying and ensuring the accuracy of analyzes and 
results. Thus, an agreement on data sharing, data 
access, data ownership, and copyright dispute 
resolution must be drawn up (48).   
Compassionate Use of Interventions 
Although the results of studies in the case of the 
COVID-19 disease have not yet confirmed the 
absolute therapeutic efficacy of a product, to lower 
the disease duration and its mortality rate, 
prescribing compassionate and off-label use of 
drugs such as chloroquine, hydroxychloroquine, 
azithromycin, lopinavir-ritonavir, favipiravir, 
remdesivir, ribavirin, interferon, convalescent 
plasma, steroids, and anti-IL-6 inhibitors has been 
proposed based on the similarity of the pathogen, 
in-vitro studies and non-definitive human studies 
(49). However, it is crucial to know that control of 
the side effects of medications and evaluation of 
their effectiveness cannot be accurately followed 
up and evaluated out of a scientifically designed 
research. 
The extensive administration of unapproved drugs 
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can result in large amounts of complications and 
costs without a noticeable effect on patients’ 
outcomes. Compassionate Use of drugs in an 
outbreak is only ethical in the situation if 1) the 
disease is serious, i.e. the mortality or morbidity 
rate is remarkable, 2) there is no effective 
treatment for the disease, 3) immediate initiation 
of the clinical trial is not possible, 4) in a scientific 
committee, evaluation of its efficacy is examined in 
details concerning the available evidence, 5) the 
resources for minimizing the risk is available, 6) 
informed consent is taken from the patients, and 6) 
its efficacy should be continuously monitored, and 
its results should be shared with the scientific 
community (20). It appears that this challenge has 
extensively occurred in off-label prescriptions in 
the recent pandemic. For example, the lack of 
conclusive scientific study has resulted in the early 
conclusion of guidance for the prescription of 
chloroquine in COVID-19. The efficacy of this drug 
on clinical outcomes of COVID-19 patients is still 
questionable, and its widespread prescription can 
lead to restricting the access of rheumatoid 
patients, such as lupus patients, to this medication, 
and results in some considerable complications (50, 
51). 
The challenge of the lack of sufficient evidence for 
examining the benefits and risks of interventions is 
not exclusive to therapeutic interventions. It seems 
that in the process of diagnosis, we don’t know 
which tests in what sequences provide an accurate 
diagnosis of COVID-19 (52). Despite its high 
sensitivity, the application of CT-scan as screening 
is not recommended, and the American College of 
Radiology recommends chest CT scan merely in 
symptomatic hospitalized patients in the case of 
presence of an indication and, forbids physicians to 
prescribe CT scan to determine who should be 
tested or admitted (53). Unfortunately, today, given 
that it has only 25% specificity, but we see the 
widespread use of this imaging even in cases where 
it has no effect on disease management, and in 
accordance with the FDA estimates, it can cause 
mortal cancer in a person out of any 2,000 people 
(54, 55).  
CONCLUSIONS 
In this article, the current ethical challenges of the 
COVID-19 pandemic were reviewed for health care 
providers and managers of the public health 
response to the pandemic. As seen in all types of 
challenges raised, the values of solidarity, utility, 
fairness, honesty, reciprocity, and the minimum 
level of restricting individual autonomy are crucial 
pillars in planning and implementing the pandemic 
response measures (56). To ensure respect for these 
ethical values, soundness, transparency, and 
responsiveness must be held in the process of 
adopting and implementing the pandemic 
response policies (57). 
The experience on the COVID-19 demonstrates that 
the scarcity of resources incurred an enormous 
shock on the health system of some countries. The 
pandemic will, unfortunately, deepen the gap of the 
health inequalities and cause the highest rate of 
mortality from poor countries with weak 
infrastructure (58). Under these conditions, the 
leadership responsibility of the WHO for using the 
capacity of all countries to decline human 
casualties of the event is of great importance. 
Solidarity, honesty, and collegiality at the local and 
global levels are the most fundamental values we 
require to control the epidemic. 
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